[go: up one dir, main page]

DE69820301D1 - Neue krystalline polymorphe form von 1-methyl-5-p-toluoylpyrrol-2-acetamidoessigsäure guaiacyl ester (med 15) - Google Patents

Neue krystalline polymorphe form von 1-methyl-5-p-toluoylpyrrol-2-acetamidoessigsäure guaiacyl ester (med 15)

Info

Publication number
DE69820301D1
DE69820301D1 DE69820301T DE69820301T DE69820301D1 DE 69820301 D1 DE69820301 D1 DE 69820301D1 DE 69820301 T DE69820301 T DE 69820301T DE 69820301 T DE69820301 T DE 69820301T DE 69820301 D1 DE69820301 D1 DE 69820301D1
Authority
DE
Germany
Prior art keywords
methyl
new
toluoylpyrrol
krystalline
med
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69820301T
Other languages
English (en)
Other versions
DE69820301T2 (de
Inventor
Sergio Anzalone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medosan Industrie Biochimiche Riunite SpA
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Medosan Industrie Biochimiche Riunite SpA
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medosan Industrie Biochimiche Riunite SpA, Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Medosan Industrie Biochimiche Riunite SpA
Application granted granted Critical
Publication of DE69820301D1 publication Critical patent/DE69820301D1/de
Publication of DE69820301T2 publication Critical patent/DE69820301T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/323—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
DE69820301T 1997-12-24 1998-12-16 Neue krystalline polymorphe form von 1-methyl-5-p-toluoylpyrrol-2-acetamidoessigsäure guaiacyl ester (med 15) Expired - Lifetime DE69820301T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT97RM000811A IT1297140B1 (it) 1997-12-24 1997-12-24 Forma cristallina del guaiacil estere dell'acido l-metil-5-p-toluoil- pirrol-2-acetammidoacetico, procedimento per la sua preparazione e
ITRM970811 1997-12-24
PCT/IT1998/000363 WO1999033797A1 (en) 1997-12-24 1998-12-16 NEW CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-p-TOLUOYLPYRROLE-2-ACETAMIDOACETIC ACID GUAIACYL ESTER (MED 15)

Publications (2)

Publication Number Publication Date
DE69820301D1 true DE69820301D1 (de) 2004-01-15
DE69820301T2 DE69820301T2 (de) 2004-10-14

Family

ID=11405418

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69820301T Expired - Lifetime DE69820301T2 (de) 1997-12-24 1998-12-16 Neue krystalline polymorphe form von 1-methyl-5-p-toluoylpyrrol-2-acetamidoessigsäure guaiacyl ester (med 15)

Country Status (21)

Country Link
US (1) US6288241B1 (de)
EP (1) EP1082304B1 (de)
JP (1) JP4693236B2 (de)
KR (1) KR100554704B1 (de)
CN (1) CN1200930C (de)
AT (1) ATE255562T1 (de)
AU (1) AU781283B2 (de)
BR (1) BR9814476A (de)
CA (1) CA2315835C (de)
CZ (1) CZ297132B6 (de)
DE (1) DE69820301T2 (de)
DK (1) DK1082304T3 (de)
ES (1) ES2210853T3 (de)
HU (1) HU228112B1 (de)
IL (1) IL136828A (de)
IT (1) IT1297140B1 (de)
PL (1) PL197768B1 (de)
PT (1) PT1082304E (de)
SK (1) SK284777B6 (de)
TR (1) TR200001867T2 (de)
WO (1) WO1999033797A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2020175023A1 (ja) * 2019-02-28 2021-12-16 国立大学法人東京工業大学 アミドの製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1210673B (it) * 1982-02-26 1989-09-20 Medosan Ind Biochimi Antinfiammatoria amidi pirrolacetiche ad attivita'
IT1148117B (it) * 1982-03-05 1986-11-26 Medosan Ind Biochimi Attivita'antiflogistica,analgesica,antipiretica,mucolitica e seda tiva della tosse dell'1 metil-5-p-tolilpirrol-2-acetato di 2'metossi-fenile
IT1197688B (it) * 1983-07-29 1988-12-06 Medosan Ind Biochimi Attivita' antiflogistica,analgesica,antipiretica ed antiaggregante piastrinica di 1-metil-5-metilbenzoilpirrol-2-acetamido acetanilidi
IT1278144B1 (it) * 1995-07-14 1997-11-17 Medosan Ricerca Srl Impiego dell'amtolmetineguacil (med 15) come farmaco antisecretivo sulla secrezione gastrica e quindi gastroprotettivo.
EP1024807B1 (de) * 1997-08-08 2003-04-16 MEDOSAN RICERCA S.r.l. Verwendung von 2-methoxyphenyl-1-methyl-5p-methyl-benzoylpyrrol-2-acetamido-acetat zur herstellung eines antientzündungsmittels mit vorbeugung von magenhypersekretion und nierenfunktionsstörung

Also Published As

Publication number Publication date
EP1082304B1 (de) 2003-12-03
IT1297140B1 (it) 1999-08-03
IL136828A (en) 2005-08-31
ES2210853T3 (es) 2004-07-01
CZ20002336A3 (cs) 2000-12-13
US6288241B1 (en) 2001-09-11
PT1082304E (pt) 2004-04-30
SK8952000A3 (en) 2000-12-11
HUP0101025A3 (en) 2001-09-28
DK1082304T3 (da) 2004-04-05
CZ297132B6 (cs) 2006-09-13
BR9814476A (pt) 2000-10-10
CN1283185A (zh) 2001-02-07
KR100554704B1 (ko) 2006-02-24
ITRM970811A1 (it) 1999-06-24
CA2315835C (en) 2008-03-25
HUP0101025A1 (hu) 2001-08-28
SK284777B6 (sk) 2005-11-03
HU228112B1 (en) 2012-11-28
WO1999033797A1 (en) 1999-07-08
AU781283B2 (en) 2005-05-12
ATE255562T1 (de) 2003-12-15
DE69820301T2 (de) 2004-10-14
TR200001867T2 (tr) 2000-12-21
PL197768B1 (pl) 2008-04-30
JP2001527064A (ja) 2001-12-25
CN1200930C (zh) 2005-05-11
PL341424A1 (en) 2001-04-09
KR20010033497A (ko) 2001-04-25
HK1035717A1 (en) 2001-12-07
CA2315835A1 (en) 1999-07-08
IL136828A0 (en) 2001-06-14
AU1782899A (en) 1999-07-19
JP4693236B2 (ja) 2011-06-01
EP1082304A1 (de) 2001-03-14

Similar Documents

Publication Publication Date Title
FI970825A7 (fi) Farmaseuttiset koostumukset, jotka aktiivisen yhdisteen biologisen hyö tyosuuden lisäämiseksi sisältävät sappisuolaa ja puskuria
MX9603520A (es) Derivados del acido hidroxamico y acido carboxilico, procesos para su preparacion y su uso.
FI953089A7 (fi) Boorihaposta johdetut uudet peptidiyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
FI964473L (fi) Uudet aminohappojohdannaiset, menetelmä niiden valmistamiseksi ja näitä yhdisteitä sisältävät farmaseuttiset koostumukset (II)
ES2158537T3 (es) Derivados de acidos ciclopropilalcanoicos.
DK0840603T3 (da) Farmaceutisk præparat af L-dopa-ethylester
DE69818286D1 (de) Pyridylverbindungen und diese enthaltende pharmazeutische zubereitungen
EA199700201A1 (ru) Парентеральные фармацевтические композиции, содержащие алкиламмониевые соли 2-арилпропиновых кислот
WO1990009993A3 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
BR9611642A (pt) Compostos composição farmacéutica e processo para a preparação de compostos
HRP20030983B1 (hr) Farmaceutski pripravak koji uključuje inhibitor lipaze i saharozne estere masne kiseline
PT736029E (pt) Sulfamatos de pseudofructopiranose anticonvulsivos
UA35607C2 (uk) Похідні оксазолідинонкарбонової кислоти, спосіб їх одержання, фармацевтична композиція і спосіб її одержання
DE69821815D1 (de) Thiocolchicin-Derivate mit entzündungshemmender und muskelrelaxierender Wirkung
NO982229D0 (no) Svovelholdige di-tert-butylfenol-forbindelser anvendbare som antiinflammatoriske midler
GEP20032924B (en) Novel Furan Diarylmethylidene Derivatives, Method for Their Preparation and Pharmaceutical Composition
DE69820301D1 (de) Neue krystalline polymorphe form von 1-methyl-5-p-toluoylpyrrol-2-acetamidoessigsäure guaiacyl ester (med 15)
BR9811954A (pt) ácidos 3-aril-succinamido-hidroxâmicos, processos para sua produção e preparações farmacêuticas contendo estas substâncias
RU94000064A (ru) Новые 2-циано-3-гидроксипропенамиды, метод их получения и содержащие их фармацевтические композиции
ATE60788T1 (de) Derivat von p-aminophenol mit mucrosekretolytischer fluessiger und antipyretischer wirksamkeit, dessen verfahren zur herstellung und dessen pharmazeutische zusammensetzungen.
AU7470098A (en) Antithrombotic agents
CO4910113A1 (es) Composiciones farmaceuticas estabilizadas, a base de quinu- pristina y de dalfopristina y su preparacion
RU95109891A (ru) 19,11-перекрытые мостиками 4-эстрены, способ их получения, содержащая их фармацевтическая композиция и промежуточные соединения для их получения
WO1998014454A3 (en) (o-ACYL-p-N-ACYLAMINO-PHENYL)-O-PHOSPHOETHANOLAMINES
AU605164B2 (en) Pharmaceutical compositions containing non-steroidal anti-inflammatory drugs

Legal Events

Date Code Title Description
8364 No opposition during term of opposition